Product Details
Januvia
Sitagliptin Phosphate Monohydrate50 mg
Tablet
DIN/PIN/NPN
02388847
Manufacturer
Merck Frosst Canada Ltd.
Formulary Listing Date
2013-09-27
Unit Price
3.2787
Amount MOH Pays
0.8197
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Sitagliptin Phosphate Monohydrate 50 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.
ATC Code
A10BH01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02388847 | Januvia | 3.2787 | 0.8197 |
| 02508664 | Apo-Sitagliptin Malate | 0.8197 | 0.8197 |
| 02529874 | Auro-Sitagliptin | 0.8197 | 0.8197 |
| 02534142 | Jamp Sitagliptin | 0.8197 | 0.8197 |
| 02504057 | Sandoz Sitagliptin | 0.8197 | 0.8197 |
| 02529041 | Sitagliptin | 0.8197 | 0.8197 |
| 02531658 | Taro-Sitagliptin Fumarate | 0.8197 | 0.8197 |
| 02512483 | Ach-Sitagliptin | 0.8197 | 0.8197 |
| 02522713 | Teva-Sitagliptin Malate | 0.8197 | 0.8197 |